MRNA

Check out our top stories of the year.

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers found.

The research aims to develop AI technologies to globally identify miRNA-target interactions in colorectal cancer patients.

Innovative research at the UF Health Cancer Center is making a meaningful difference for those affected by cancer.

The trial will test a novel UF-developed mRNA lipid nanoparticle (RNA-LP) in two pediatric cancers.

An article in The Economist highlights how cancer vaccines are showing promise.

An mRNA cancer vaccine developed at the University of Florida has attracted widespread news coverage.

The breakthrough by UF Health Cancer Center researchers now will be tested in a Phase 1 pediatric clinical trial for brain cancer.